ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
19F nuclear magnetic resonance spectroscopy experiments seem to have resolved uncertainties about the transition-state intermediate of a key process in sugar metabolism—the β-phosphoglucomutase-catalyzed transfer of a phosphoryl group to a substrate. A few years ago, Karen N. Allen of the Boston University School of Medicine, Debra Dunaway-Mariano of the University of New Mexico, Albuquerque, and coworkers obtained the first crystallographic view of β-phosphoglucomutase’s transition state, finding that an unprecedented trigonal bipyramidal oxyphosphorane intermediate was involved in the transfer (Science 2003, 299, 2067). But a team including G. Michael Blackburn of the University of Sheffield claimed that other experimental evidence indicated the intermediate is MgF3–, not oxyphosphorane. 19F NMR studies by Blackburn, his Sheffield colleague Jonathan P. Waltho, and coworkers now confirm that MgF3– is the intermediate (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.0910333106). The new evidence resolves the issue, Blackburn notes, because X-ray crystallography cannot differentiate fluorine from oxygen at resolutions common for protein crystals, whereas 19F NMR can. Allen comments, “It would be exciting if the group can demonstrate generality by showing the existence of MgF3– in other phosphoryl-transfer enzymes.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X